Continuing Education Online Courses
The continuing medical education online activities listed below include topics in a wide variety of therapeutic areas. We feature a variety of formats and learning opportunities to suit your needs. All content is developed and approved by experts and includes up-to-date data and research. Whether you are participating from your office, at home, or via mobile device, we offer continuing education online courses for you. Browse through the subjects below or click Therapeutic Areas above to find educational opportunities in your content area.
Alpha-1 Antitrypsin Deficiency
In this educational activity, which is based on a symposium held during the American Psychiatric Nurses Association 17th Annual Clinical Psychopharmacology Institute meeting, you will hear from a live adolescent patient with bipolar disorder and her caregiver, as well as 2 faculty experts. You will have an opportunity to learn more about the diagnosis and treatment for pediatric and adolescent bipolar disorder through challenging clinical case presentations, clinical questions, and a panel discussion highlighting the personal impact of bipolar disorder.
The panel will delve into topics covering safety/efficacy data for PCSK9 inhibitors (PCSK9-Is), 2018 ACC/AHA guideline updates, and patient selection for treatment intensification with PCSK9-Is. Faculty will examine key matters in patient care, provide illustrative patient case scenarios, pose practical solutions to common issues encountered in clinical practice, and Charles will provide insight into his experience with FH, its treatment, and his interaction with the healthcare system.
In this interactive roundtable discussion, Charles, his doctor, and 2 other prominent clinical experts gather to deliberate over reimbursement issues surrounding the clinical use of PCSK9-Is and offer practical strategies to facilitate navigating the prior authorization and appeals process.
This unique educational initiative harnesses the power of reflection and recognition of suboptimal approaches to patient care to allow you to rethink clinical decisions based on the scenarios presented, and to modify treatment plans accordingly. You can compare your responses to interactive questions with those of your peers and learn from our expert faculty.
This activity is designed to engage your critical thinking and challenge suboptimal approaches to patient care. It features videos of 2 patients with CU and challenging interactive questions related to their histories and treatments. You will have an opportunity to hear the patients’ perspectives of CU, and learn from our expert faculty.
Cutaneous Squamous Cell Carcinoma
This enduring activity will provide learners with the latest developments in immunotherapy for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.
This CME activity for hematologists is interactive and fast-paced, allowing you to test your knowledge, practice through a series of questions including case vignettes, and find out what the experts have to say about new developments and unmet patient needs in hemophilia A.
In this CME activity, you will hear insights from 3 hemophilia experts on the current management approach to hemophilia A with and without inhibitors, new developments in hemophilia A therapies, and ways to incorporate shared decision making when treating patients with hemophilia A. In addition, you will have an opportunity to practice through a series of questions and compare yourself to your peers.
Inflammatory Bowel Diseases
This case-based activity is designed to increase your knowledge and skills in providing individualized care to your patients with inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC). Underpinned by evidence-based medicine and aided by clinical commentary, this activity will address challenges commonly faced in daily clinical care.
Advances in inflammatory bowel disease (IBD) treatment have improved outcomes for many patients but personalizing therapy and predicting response to therapy is a huge challenge. This has led to underutilization of effective regimens, undertreatment, and suboptimal outcomes. This activity reviews how new and emerging clinical decision support tools can help providers bridge this gap by predicting individualized disease complication risk and response to therapy.
Join leading IBD experts in this interactive activity where you will have the opportunity to follow a patient to learn about the diagnosis and management of IBD. Be sure to check out the Crohn's & Colitis Foundation resources as well as a comprehensive reading list related to the learning objectives following the closing commentary section of the activity.
Join leading IBD experts in this interactive activity where you will have the opportunity to follow a patient to learn about the long-term management and surgery indications of IBD. Be sure to check out the Crohn's & Colitis Foundation resources as well as a comprehensive reading list related to the learning objectives following the closing commentary section of the activity.
Underpinned by the American Gastroenterological Association (AGA) Clinical Care Pathways and evidence-based literature, this activity will highlight the best practices in the treatment of patients with IBD. Incorporating these care pathways into your daily clinical practice will ensure that patients receive the best standard of care currently available.
Small Cell Lung Cancer
Solid Organ Transplant
This educational activity is based on the proceedings of a symposium at the 2018 American Transplant Congress. Drs. Deepali Kumar and Alexandre Loupy present new data and challenging clinical cases in cytomegalovirus (CMV) and antibody-mediated rejection (AMR) in transplantation. You will have an opportunity to assess your skills in CMV and AMR and compare your responses to your peers when you answer interactive questions throughout the activity.
This panel discussion is designed to increase your knowledge in recognizing risk for and understanding the burden of cytomegalovirus (CMV) and Clostridium difficile infection (CDI) in hematopoietic stem cell transplantation (HSCT) patients. Underpinned by evidence-based medicine, this activity will address challenges commonly faced in daily clinical care.
This activity features a panel discussion and is designed to increase your skills in providing individualized care to your patients who have had a hematopoietic stem cell transplantation (HSCT) and are at risk for cytomegalovirus (CMV) and Clostridium difficile infection (CDI). Aided by clinical commentary, this activity will address challenges commonly faced in daily clinical care.